---
$id: https://graph.org.ai/products/commodity/51442716
$type: Product
source: UNSPSC
code: "51442716"
title: "Technetium Tc-99m sestamibi or technetium 99mtc sestamibi"
class: "51442700"
classTitle: "Technetium-based radiopharmaceuticals, imaging agents, media, and tracers"
family: "51440000"
familyTitle: "Radiopharmaceuticals and contrast media"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Technetium Tc-99m sestamibi or technetium 99mtc sestamibi

**UNSPSC Code**: 51442716
**Class**: [Technetium-based radiopharmaceuticals, imaging agents, media, and tracers](Technetium-based radiopharmaceuticals, imaging agents, media, and tracers.mdx)
**Family**: [Radiopharmaceuticals and contrast media](../Radiopharmaceuticals and contrast media.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a radioconjugate with the molecular formula C36H66N6O6TC, a contrast medium that practitioners use in myocardial perfusion studies, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 971Z4W1S09, more generally known as Technetium Tc-99m sestamibi. The European Medicines Agency schedules Technetium Tc 99m sestamibi in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10857MIG. The term Technetium Tc 99m SESTAMIBI is an International Non-Proprietary Name or INN. Most nations schedule Technetium Tc-99m sestamibi or technetium 99mtc sestamibi under HS 28444030.

